Indian Journal of Medical Microbiology IAMM  | About us |  Subscription |  e-Alerts  | Feedback |  Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Ahead of Print | Current Issue | Archives | Search | Instructions  
Users Online: 65 Official Publication of Indian Association of Medical Microbiologists 
Read this article

 


    Article Cited by others

ORIGINAL ARTICLE

Evaluation of immunogenicity and safety of Genevac B: A new recombinant hepatitis b vaccine in comparison with Engerix B and Shanvac B in healthy adults

Vijayakumar V, Hari R, Parthiban R, Mehta J, Thyagarajan S P

Year : 2004| Volume: 22| Issue : 1 | Page no: 34-38

   This article has been cited by
 
1 Evaluation of a recombinant DNA hepatitis b vaccine in a vaccinated Nigerian population
Adoga, M.P., Pennap, G., Akande, B.O., Mairiga, J.P., Pechulano, S., Agwale, S.M.
Journal of Infection in Developing Countries. 2010; 4(11): 740-744
[Pubmed]  [Google Scholar]
2 Seroprotection after hepatitis B vaccination in chronic kidney disease patients with modified schedule and dosage
Siddiqui, S., Malik, A., Shukla, I., Rizvi, M., Haque, S.F.
Journal of Infection in Developing Countries. 2010; 4(6): 389-392
[Pubmed]  [Google Scholar]
3 Immunization facts: Adult need their shots
Kumar, D., Langer, B., Sing, Z.
JK Science. 2009; 11(1): 49-50
[Pubmed]  [Google Scholar]
4 Relationship between T-lymphocyte cytokine levels and sero-response to hepatitis B vaccines
Velu, V., Saravanan, S., Nandakumar, S., Shankar, E.M., Vengatesan, A., Jadhav, S.S., Kulkarni, P.S., Thyagarajan, S.P.
World Journal of Gastroenterology. 2008; 14(22): 3534-3540
[Pubmed]  [Google Scholar]
5 Comparative efficacy of two dosages of recombinant hepatitis B vaccine in healthy adolescents in India
Velu, V., Nandakumar, S., Shanmugam, S., Shankar, E.M., Thangavel, S., Kulkarni, P.S., Thyagarajan, S.P.
Pediatric Infectious Disease Journal. 2007; 26(11): 1038-1041
[Pubmed]  [Google Scholar]
6 Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in small infants: A randomized, double-blind comparative study
Sapru, A., Kulkarni, P.S., Bhave, S., Bavdekar, A., Naik, S.S., Pandit, A.N.
Journal of Tropical Pediatrics. 2007; 53(5): 303-307
[Pubmed]  [Google Scholar]
7 Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure
Rajapurkar, M.M., Gang, S., Dabhi, M., Kulkarni, P.S.
Journal of Nephrology. 2007; 20(5): 596-601
[Pubmed]  [Google Scholar]
8 Comparison of three different recombinant hepatitis B vaccines: GeneVac-B, Engerix B and Shanvac B in high risk infants born to HBsAg positive mothers in India
Velu, V., Nandakumar, S., Shanmugam, S., Jadhav, S.S., Kulkarni, P.S., Thyagarajan, S.P.
World Journal of Gastroenterology. 2007; 13(22): 3084-3089
[Pubmed]  [Google Scholar]
9 Comparison of two hepatitis B vaccines (GeneVac-B and Engerix-B) in healthy infants in India
Shivananda, Somani, V., Srikanth, B.S., Mohan, M., Kulkarni, P.S.
Clinical and Vaccine Immunology. 2006; 13(6): 661-664
[Pubmed]  [Google Scholar]
10 Immunogenicity of a new, low-cost recombinant hepatitis B vaccine derived from Hansenula polymorpha in adults
Kulkarni, P.S., Raut, S.K., Patki, P.S., Phadke, M.A., Jadhav, S.S., Kapre, S.V., Dhorje, S.P., Godse, S.R.
Vaccine. 2006; 24(17): 3457-3460
[Pubmed]  [Google Scholar]

 

© 2004 - Indian Journal of Medical Microbiology
Published by Medknow

Online since April 2001, new site since 1st August '04